ITEM 1.01 Entry into a Material Definitive Agreement.

On December 24, 2021, Intra-Cellular Therapies, Inc. (the "Company") entered into the Amendment (the "Amendment") to the Supply Agreement dated as of January 4, 2017 (the "Supply Agreement") by and between Siegfried Evionnaz SA ("Siegfried") and ITI Limited, a wholly-owned subsidiary of the Company, to extend the current term of the Supply Agreement until January 4, 2023.

The foregoing summary of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, which is attached as Exhibit 10.1 to this Current Report on Form 8-K.

ITEM 9.01 Financial Statements and Exhibits.




(d)  Exhibits



Exhibit
Number                                    Description

10.1           Amendment to Supply Agreement dated as of December 24, 2021 by and
             between Siegfried Evionnaz SA and ITI Limited

104          Cover Page Interactive Data File (embedded within the Inline XBRL
             document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses